What is Archit Organosys Ltd (524640) share price return in the past 10 years?

Archit Organosys Ltd share price has appreciated 16.3% annually (CAGR) over the past ten years.

What is the share price of Archit Organosys Ltd (524640)?

Company share prices are keep on changing according to the market conditions. The current trading price of Archit Organosys Ltd (524640) on 03-Jul-2026 09:39:00 at 09:39 is 61.98.

What is the P/E ratio of Archit Organosys?

The latest standalone P/E ratio of Archit Organosys as of 03-Jul-2026 is 15.63.

What is the P/B ratio of Archit Organosys Ltd (524640)?

The latest standalone P/B ratio of Archit Organosys Ltd (524640) as of 03-Jul-2026 is 1.65.

What is the 52-week high and low of Archit Organosys Ltd (524640)?

The 52-week high of Archit Organosys Ltd (524640) is Rs. 64.60 and the 52-week low is Rs. 34.00.

Archit Organosys Ltd (524640) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Archit Organosys Ltd (524640)
Brand: Archit Organosys

Archit Organosys Ltd (524640)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524640 NSE: Chemicals | Small Cap | Archit Organosys Share Price

Archit Organosys Ltd (524640)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524640 NSE: Chemicals | Small Cap | Archit Organosys Share Price

Key Metrics

Valuation Multiples

Market Cap

₹126 Cr.

Current Price

₹62

52-Week Low / High

₹34 / 65

TTM EPS

₹3.9

TTM Sales

₹141 Cr.

Book Value per Share

₹37.2

P/E Ratio

15.63

Higher than its 5-year historical median

Industry PE

52.9

Price to Book (P/B)

1.65

In line with its 5-year historical median

Price to Sales (P/S)

0.89

Higher than its 5-year historical median

EV/EBITDA

7.67

In line with its 5-year historical median

Dividend Yield

0.81%

Profitability Efficiency

Return on Equity (ROE)

7.58%

Underperforms industry median

Return on Capital Employed (ROCE)

10.88%

Underperforms industry median

Return on Assets (ROA)

4.34%

Operating Profit Margin

10.3%

Net Profit Margin

4.02%

Gross Profit Margin

10.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

10.96%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

92.15%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

51.2%

Asset Quality

Promoter Holding

65.88%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹56 Cr.

Equity

₹20.5 Cr.

Face Value

₹10

All Time Low / High

₹0.53 / 100.00

Archit Organosys stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Archit Organosys Ltd a good quality company?

Archit Organosys Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Archit Organosys Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Archit Organosys Ltd vs industry peers?

Archit Organosys Ltd revenue CAGR is 10.37%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Archit Organosys Ltd?

Promoters hold 65.88% of the Archit Organosys Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Archit Organosys Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 11.7% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	17.4%	8.9%	6.3%	-3.6%	3.4%	11.5%	18%	19.9%	7.6%	10.9%	-
Value Creation Index ⓘ	0.2	-0.4	-0.6	-1.3	-0.8	-0.2	0.3	0.4	-0.5	-0.2	-
Growth Parameters ⓘ
Sales ⓘ	51.4	48	81.5	84	76.7	94.5	138	128	113	126	141
Sales YoY Gr.	-	-6.5%	69.8%	3%	-8.7%	23.2%	45.9%	-7.3%	-11.4%	11%	-
Adj EPS ⓘ	1.3	1.6	0.3	-3.2	-0.6	3.5	3.9	4.9	0.3	2.4	3.9
YoY Gr.	-	21.7%	-84.1%	-1376%	NA	NA	13%	25.4%	-93.1%	597.1%	-
BVPS (₹) ⓘ	13.6	26.5	26.3	23.2	22.7	26.1	25.3	30.1	31.3	33.7	37.2
Adj Net Profit ⓘ	1.2	1.6	0.4	-4.8	-0.8	5.2	8	10	0.7	4.9	8
Cash Flow from Ops. ⓘ	0.9	2.3	-3.8	2.8	7.7	11.1	10.6	18	10.2	18.5	-
Debt/CF from Ops. ⓘ	12.3	13.7	-9.6	13.5	4.3	2.7	3	1.7	2.5	1.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.5%	10.4%	-3.1%	11%
Adj EPS ⓘ	7%	NA	-15.3%	597.1%
BVPSⓘ	10.6%	8.2%	10.1%	7.9%
Share Price	16.3%	5.3%	3.7%	40.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	13.4	8	1.2	-12.9	-2.4	13.9	17.3	17.7	1.1	7.3	11
Op. Profit Mgn % ⓘ	6.2	8.1	4.9	-3.4	4.7	12	12	15.3	6.1	10.3	11.6
Net Profit Mgn % ⓘ	2.4	3.3	0.5	-5.7	-1.1	5.5	5.8	7.9	0.6	3.9	5.7
Debt to Equity ⓘ	0.9	1.2	0.9	1.1	1	0.8	0.6	0.5	0.4	0.4	0
Working Cap Days ⓘ	117	142	152	163	134	116	96	131	144	147	81
Cash Conv. Cycle ⓘ	44	44	50	61	44	39	41	45	45	23	24

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	51	48	82	84	77	95	138	128	113	126
Operating Expenses ⓘ +	48	44	78	87	73	83	122	109	106	113
Manufacturing Costs	5	4	5	7	10	11	11	15	13	14
Material Costs	34	33	61	69	52	60	96	77	78	85
Employee Cost	2	2	5	5	6	6	7	7	6	7
Other Costs ⓘ	7	5	6	5	5	6	9	9	9	7
Operating Profit ⓘ	3	4	4	-3	4	11	16	19	7	13
Operating Profit Margin (%)	6.2%	8.0%	4.8%	-3.6%	4.7%	11.7%	11.6%	14.8%	6.0%	10.3%
Other Income ⓘ +	1	0	3	3	2	1	2	2	3	3
Exceptional Items ⓘ	0	0	0	0	0	0	0	2	3	0
Interest ⓘ	1	1	4	4	3	3	2	2	3	3
Depreciation ⓘ	0	1	3	3	3	4	5	5	6	6
Profit Before Tax ⓘ	2	3	0	-6	-1	5	11	15	4	8
Tax ⓘ	1	1	-0	-2	0	-0	3	4	1	2
Profit After Tax	1	2	1	-5	-1	5	8	11	3	5
PAT Margin (%)	2.9%	3.6%	0.6%	-5.6%	-1.0%	5.3%	6.0%	8.9%	3.0%	4.0%
Adjusted EPS (₹)	1.5	1.7	0.3	-3.1	-0.5	3.3	4.0	5.6	1.6	2.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	18.70%	9%	0%	20.30%

Valuation of Archit Organosys - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	13	27	40	35	34	39	52	62	64	69
Share Capital ⓘ	5	10	15	15	15	15	21	21	21	21
Reserves ⓘ	8	17	25	20	19	24	31	41	44	49
Debt +	11	30	27	31	27	22	24	26	21	24
Long Term Debt	3	25	19	18	12	12	12	14	8	4
Short Term Debt	8	5	8	14	14	10	12	11	14	19
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	7	22	11	13	15	14	23	13	22
Others Liabilities ⓘ	2	6	14	8	9	11	16	14	10	9
Total Liabilities ⓘ	32	70	103	85	83	86	105	124	109	124
Fixed Assets
Net Fixed Assets ⓘ +	6	47	47	47	50	48	45	50	60	54
Gross Block	8	50	52	55	61	61	63	70	84	83
Accumulated Depreciation	2	2	5	8	11	14	18	19	24	29
CWIP ⓘ	8	1	8	5	1	3	13	14	1	1
Investments ⓘ	0	0	0	0	0	0	1	4	6	6
Inventories	3	2	7	6	3	4	6	3	3	4
Trade Receivables	11	11	31	14	20	25	27	37	22	23
Cash Equivalents	1	1	1	5	3	4	5	5	4	0
Others Assets ⓘ	3	7	8	8	5	3	8	10	13	35
Total Assets ⓘ	32	70	103	85	83	86	105	124	109	124

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1	2	-4	3	8	11	11	18	10	19
PBT ⓘ	2	3	0	-6	-1	5	11	15	4	8
Adjustment ⓘ	1	1	6	6	6	7	6	4	1	5
Changes in Working Capital ⓘ	-2	-1	-10	3	3	-1	-6	1	6	7
Tax Paid ⓘ	-1	-1	-0	-0	-0	-0	-1	-3	-1	-1
Cash Flow From Investing Activity ⓘ +	-8	-35	-9	1	-1	-3	-12	-11	-2	-21
Capex	-8	-35	-9	1	-5	-0	-1	-9	5	-0
Net Investments	0	0	0	0	0	-0	-1	-2	-2	-0
Others ⓘ	0	0	0	1	4	-3	-9	-1	-5	-20
Cash Flow From Financing Activity ⓘ +	7	32	13	0	-9	-7	2	-7	-9	-1
Net Proceeds from Shares ⓘ	6	12	12	0	0	0	4	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	-1	-7	-3
Interest Paid ⓘ	-1	-1	-4	-4	-3	-3	-2	-3	-3	-3
Dividend Paid ⓘ	0	0	0	0	0	0	-1	-1	-1	-0
Others ⓘ	2	21	5	4	-6	-4	2	-1	2	4
Net Cash Flow ⓘ	-0	-0	0	4	-2	1	2	-0	-1	-4

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	15.84	8.65	1.54	-12.65	-2.32	13.67	18.08	20.09	5.3	7.58
ROCE (%)	17.42	8.92	6.3	-3.58	3.42	11.52	17.96	19.9	7.63	10.88
Asset Turnover Ratio	1.85	0.95	0.95	0.9	0.92	1.12	1.44	1.11	0.97	1.08
PAT to CFO Conversion(x)	1	1	-4	N/A	N/A	2.2	1.38	1.64	3.33	3.8
Working Capital Days
Receivable Days	79.50	84.30	95.40	99.30	81.10	86.40	69.30	92.40	96.10	65.80
Inventory Days	21.20	19.90	21.40	28.20	21.70	13.20	12.50	13.30	11	11.30
Payable Days	76.80	75.60	86.90	85	82.40	83.50	53.80	87	85	75.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Archit Organosys Ltd FAQs

The current trading price of Archit Organosys on 03-Jul-2026 09:39 is ₹61.98.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Jul-2026 the market cap of Archit Organosys stood at ₹125.5 Cr

The latest P/E ratio of Archit Organosys as of 02-Jul-2026 is 15.63.

The latest P/B ratio of Archit Organosys as of 02-Jul-2026 is 1.65.

The 52-week high of Archit Organosys is ₹64.60 and the 52-week low is ₹34.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Archit Organosys is ₹141 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Archit Organosys Ltd is a average quality company.

The key valuation ratios of Archit Organosys Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Archit Organosys Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Archit Organosys Ltd

Shri Chlochem Ltd. has been on the forefront in the Indian chemical industry, ever since its inception in 1989. The company has its roots in the multifaceted Archit Group and closely associates with other firms of the same group viz.Archit Polymers Pvt. Limited (manufacturing and trading of organic chemicals), Krishna Orgo Chem. (trading of chemicals and ancillaries). This conglomeration has proved itself to be a market center, for manufacturing and catering to almost every requirement in the chemical industry.

The product line is composed of monochloro acetic acid, sodium monochloro acetate, chloro acetyl chloride and prganic pigments.

Apart from being one of the leading companies, in chemical manufacturing & exports, the company has vast resources and infrastructural facilities. The company is presently undergoing a major expansion in its production capacity, which will enable it to increase its present capacity by more than double.

Shri Chlochem provides quality and services of the topmost standards. The customersâ€™ satisfaction and benefit are the laid goals at Shri Chlochem and this has caused them to maintain an ever -growing chain of successful customers.

Product range of the company includes:

Monochloro Acetic Acid (MCA)
Sodium Monochloro Acetate (SMCA)
Pigment
Shade Card

Achievements/ recognition:

The company is ISO 9001 certified

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Archit Organosys Ltd (524640)

Archit Organosys Ltd (524640)

Archit Organosys stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Archit Organosys - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Archit Organosys Ltd FAQs

What is the share price of Archit Organosys?

What is the market cap of Archit Organosys?

What is the P/E ratio of Archit Organosys?

What is the P/B ratio of Archit Organosys?

What is the 52-week high and low of Archit Organosys?

What is the TTM revenue of Archit Organosys?

Is Archit Organosys Ltd a good quality company?

Is Archit Organosys Ltd undervalued or overvalued?

Is Archit Organosys Ltd a good buy now?

About Archit Organosys Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.